Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats
- PMID: 16307294
- DOI: 10.1007/s00213-005-0225-y
Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats
Abstract
Rationale: In previous drug discrimination studies we observed surmountable antagonism by Delta(9)-tetrahydrocannabinol (THC) in the presence of constant doses of SR-141716 [N-(piperidin-1-yl)-5-(4-chloro-phenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide] (0.3 and 1 mg/kg), but there was only marginal evidence for surmountable antagonism with combinations of SR-141716 and (R)-methanandamide, a chiral analog of the endocannabioid anandamide.
Objective: Here we examine antagonism where the cannabinoid CB1 receptor agonist [Delta(9)-THC and (R)-methanandamide] dose is held constant (i.e., the training dose) and the antagonist {i.e., SR-141716 and AM-251 [N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide; 2 ml/kg]} dose varied. We also tested the cannabinoid CB2 receptor antagonist SR-144528 {N-[(1S)-endo-1,3,3-trimethylbicyclo(2.2.1)heptan-2-yl]5-(4-chloro-3-methyl-phenyl)-1-(4-methylbenzyl)pyrazole-3-carboxamide}.
Methods: Different groups of rats were trained to discriminate between vehicle and three different doses of Delta(9)-THC (1.8, 3, and 5.6 mg/kg, presumably reflecting different efficacy demands) as well as 10 mg/kg (R)-methanandamide. Dose-generalization tests involved different doses of the cannabinoid CB1 receptor agonists. Antagonist tests varied the dose of the antagonist (range: 0.1 and 3 mg/kg for SR-141716 and AM-251, and 1 to 10 mg/kg for SR-144528).
Results: SR-141716 and AM-251 doses dependently blocked the agonist-induced discriminative stimulus effects. SR-141716 tended to be slightly more potent than AM-251. The effective dose 50 (ED(50)) of SR-141716 was higher in the 5.6 mg/kg Delta(9)-THC-trained group relative to the two other Delta(9)-THC-trained groups. The cannabinoid CB2 receptor antagonist SR-144528 combined with the training dose of 1.8 mg/kg Delta(9)-THC, as well as when combined with the training dose of 10 mg/kg (R)-methanandamide, did not markedly change drug-appropriate (agonist) responses.
Conclusion: Data support that the discriminative stimulus effects of (R)-methanandamide and its overlap with the Delta(9)-THC cue are, indeed, CB1 receptor mediated events as revealed in antagonism tests with the selective central CB1 receptor antagonists SR-141716 and AM-251. The activation of cannabinoid CB2 receptors appears to be insignificant for these discriminations.
Similar articles
-
Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.Br J Pharmacol. 2015 Feb;172(3):737-53. doi: 10.1111/bph.12944. Br J Pharmacol. 2015. PMID: 25257544 Free PMC article. Review.
-
[Drug discrimination properties and cytotoxicity of the cannabinoid receptor ligands].Nihon Arukoru Yakubutsu Igakkai Zasshi. 2012 Jun;47(3):135-43. Nihon Arukoru Yakubutsu Igakkai Zasshi. 2012. PMID: 22894054 Review. Japanese.
-
Discriminative stimulus functions of AM-1346, a CB1R selective anandamide analog in rats trained with Delta9-THC or (R)-methanandamide (AM-356).Psychopharmacology (Berl). 2006 Oct;188(3):315-23. doi: 10.1007/s00213-006-0517-x. Epub 2006 Sep 5. Psychopharmacology (Berl). 2006. PMID: 16953384
-
Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.J Pharmacol Exp Ther. 2006 Dec;319(3):1211-8. doi: 10.1124/jpet.106.107110. Epub 2006 Aug 30. J Pharmacol Exp Ther. 2006. PMID: 16943255
-
(R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.Psychopharmacology (Berl). 2001 Aug;156(4):369-80. doi: 10.1007/s002130100730. Psychopharmacology (Berl). 2001. PMID: 11498713
Cited by
-
Δ9-Tetrahydrocannabinol discrimination: Effects of route of administration in rats.Drug Alcohol Depend. 2021 Aug 1;225:108827. doi: 10.1016/j.drugalcdep.2021.108827. Epub 2021 Jun 23. Drug Alcohol Depend. 2021. PMID: 34186444 Free PMC article.
-
Do you feel it now? Route of administration and Δ9-tetrahydrocannabinol-like discriminative stimulus effects of synthetic cannabinoids in mice.Neurotoxicology. 2019 Jul;73:161-167. doi: 10.1016/j.neuro.2019.04.002. Epub 2019 Apr 3. Neurotoxicology. 2019. PMID: 30953678 Free PMC article.
-
Comparison of the discriminative stimulus and response rate effects of Δ9-tetrahydrocannabinol and synthetic cannabinoids in female and male rats.Drug Alcohol Depend. 2017 Mar 1;172:51-59. doi: 10.1016/j.drugalcdep.2016.11.035. Epub 2017 Jan 11. Drug Alcohol Depend. 2017. PMID: 28130989 Free PMC article.
-
Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice.Neuropharmacology. 2016 Nov;110(Pt A):143-153. doi: 10.1016/j.neuropharm.2016.07.016. Epub 2016 Jul 20. Neuropharmacology. 2016. PMID: 27449567 Free PMC article.
-
Discriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids.Curr Top Behav Neurosci. 2018;39:153-173. doi: 10.1007/7854_2016_24. Curr Top Behav Neurosci. 2018. PMID: 27278640 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials